These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27406814)

  • 1. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
    Fall T; Salihovic S; Brandmaier S; Nowak C; Ganna A; Gustafsson S; Broeckling CD; Prenni JE; Kastenmüller G; Peters A; Magnusson PK; Wang-Sattler R; Giedraitis V; Berne C; Gieger C; Pedersen NL; Ingelsson E; Lind L
    Diabetologia; 2016 Oct; 59(10):2114-24. PubMed ID: 27406814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicohort Metabolomics Analysis Discloses 9-Decenoylcarnitine to Be Associated With Incident Atrial Fibrillation.
    Lind L; Salihovic S; Sundström J; Broeckling CD; Magnusson PK; Prenni J; Fall T; Ärnlöv J
    J Am Heart Assoc; 2021 Jan; 10(2):e017579. PubMed ID: 33399003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black South African women: a prospective cohort study.
    Zeng Y; Mtintsilana A; Goedecke JH; Micklesfield LK; Olsson T; Chorell E
    Metabolism; 2019 Jun; 95():57-64. PubMed ID: 30954560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population.
    Stenemo M; Ganna A; Salihovic S; Nowak C; Sundström J; Giedraitis V; Broeckling CD; Prenni JE; Svensson P; Magnusson PKE; Lind L; Ingelsson E; Ärnlöv J; Fall T
    ESC Heart Fail; 2019 Aug; 6(4):764-773. PubMed ID: 31148414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term NO2 exposure is associated with long-chain fatty acids in prospective cohorts from Augsburg, Germany: results from an analysis of 138 metabolites and three exposures.
    Ward-Caviness CK; Breitner S; Wolf K; Cyrys J; Kastenmüller G; Wang-Sattler R; Schneider A; Peters A
    Int J Epidemiol; 2016 Oct; 45(5):1528-1538. PubMed ID: 27892410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke.
    Lind L; Salihovic S; Ganna A; Sundström J; Broeckling CD; Magnusson PK; Pedersen NL; Siegbahn A; Prenni J; Fall T; Ingelsson E; Ärnlöv J
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104476. PubMed ID: 31806450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study.
    Nowak C; Salihovic S; Ganna A; Brandmaier S; Tukiainen T; Broeckling CD; Magnusson PK; Prenni JE; Wang-Sattler R; Peters A; Strauch K; Meitinger T; Giedraitis V; Ärnlöv J; Berne C; Gieger C; Ripatti S; Lind L; Pedersen NL; Sundström J; Ingelsson E; Fall T
    PLoS Genet; 2016 Oct; 12(10):e1006379. PubMed ID: 27768686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts.
    Ahola-Olli AV; Mustelin L; Kalimeri M; Kettunen J; Jokelainen J; Auvinen J; Puukka K; Havulinna AS; Lehtimäki T; Kähönen M; Juonala M; Keinänen-Kiukaanniemi S; Salomaa V; Perola M; Järvelin MR; Ala-Korpela M; Raitakari O; Würtz P
    Diabetologia; 2019 Dec; 62(12):2298-2309. PubMed ID: 31584131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.
    de Mello VD; Paananen J; Lindström J; Lankinen MA; Shi L; Kuusisto J; Pihlajamäki J; Auriola S; Lehtonen M; Rolandsson O; Bergdahl IA; Nordin E; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Landberg R; Eriksson JG; Tuomilehto J; Hanhineva K; Uusitupa M
    Sci Rep; 2017 Apr; 7():46337. PubMed ID: 28397877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics analysis reveals that bile acids and phospholipids contribute to variable responses to low-temperature-induced ascites syndrome.
    Shen Y; Shi S; Tong H; Guo Y; Zou J
    Mol Biosyst; 2014 Jun; 10(6):1557-67. PubMed ID: 24700147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.
    Xu F; Tavintharan S; Sum CF; Woon K; Lim SC; Ong CN
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1060-5. PubMed ID: 23633210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes.
    Xu T; Brandmaier S; Messias AC; Herder C; Draisma HH; Demirkan A; Yu Z; Ried JS; Haller T; Heier M; Campillos M; Fobo G; Stark R; Holzapfel C; Adam J; Chi S; Rotter M; Panni T; Quante AS; He Y; Prehn C; Roemisch-Margl W; Kastenmüller G; Willemsen G; Pool R; Kasa K; van Dijk KW; Hankemeier T; Meisinger C; Thorand B; Ruepp A; Hrabé de Angelis M; Li Y; Wichmann HE; Stratmann B; Strauch K; Metspalu A; Gieger C; Suhre K; Adamski J; Illig T; Rathmann W; Roden M; Peters A; van Duijn CM; Boomsma DI; Meitinger T; Wang-Sattler R
    Diabetes Care; 2015 Oct; 38(10):1858-67. PubMed ID: 26251408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
    Abu Bakar MH; Sarmidi MR
    Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS.
    Liu L; Wang M; Yang X; Bi M; Na L; Niu Y; Li Y; Sun C
    Clin Chem; 2013 Sep; 59(9):1338-48. PubMed ID: 23620415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.
    Suhre K; Meisinger C; Döring A; Altmaier E; Belcredi P; Gieger C; Chang D; Milburn MV; Gall WE; Weinberger KM; Mewes HW; Hrabé de Angelis M; Wichmann HE; Kronenberg F; Adamski J; Illig T
    PLoS One; 2010 Nov; 5(11):e13953. PubMed ID: 21085649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes.
    Jäger S; Wahl S; Kröger J; Sharma S; Hoffmann P; Floegel A; Pischon T; Prehn C; Adamski J; Müller-Nurasyid M; Waldenberger M; Strauch K; Peters A; Gieger C; Suhre K; Grallert H; Boeing H; Schulze MB; Meidtner K
    Sci Rep; 2017 Jul; 7(1):6037. PubMed ID: 28729637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biomarkers for pre-diabetes identified by metabolomics.
    Wang-Sattler R; Yu Z; Herder C; Messias AC; Floegel A; He Y; Heim K; Campillos M; Holzapfel C; Thorand B; Grallert H; Xu T; Bader E; Huth C; Mittelstrass K; Döring A; Meisinger C; Gieger C; Prehn C; Roemisch-Margl W; Carstensen M; Xie L; Yamanaka-Okumura H; Xing G; Ceglarek U; Thiery J; Giani G; Lickert H; Lin X; Li Y; Boeing H; Joost HG; de Angelis MH; Rathmann W; Suhre K; Prokisch H; Peters A; Meitinger T; Roden M; Wichmann HE; Pischon T; Adamski J; Illig T
    Mol Syst Biol; 2012; 8():615. PubMed ID: 23010998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.